Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Wang tells PV Tech Premium that copper offers a ‘a compelling combination’ of traits to replace silver. Image: AIKO. This Premium article, which was one of the most read Premium articles in 2025, has ...